AXGN · 10-Q · 2026Q1 · Full report

Capital Raise and Use of Proceeds

Axogen, Inc. · 2026-04-28 · Importance 71 · Surprise 60

On January 23, 2026, Axogen closed an upsized public offering with the sale of 4,600,000 shares of common stock, yielding net proceeds of $133,252.,From these net proceeds, $69,707 were used to fully repay and terminate the Company's Credit Facility on January 28, 2026.,The filing states remaining funds from the offering are available for working capital, capital expenditures and other general corporate purposes as of Q1 2026.

Key facts

• Net cash provided by financing activities increased $57,123 primarily due to net proceeds from the Offering and proceeds from the exercise of stock options, partially offset by cash used for early payoff and termination of the Credit Facility and payments of employee tax withholding on vested stock awards
• On January 23, 2026, Axogen closed an upsized public offering with the sale of 4,600,000 shares of common stock yielding net proceeds of $133,252
• From the net proceeds of the Offering, $69,707 were used to fully repay and terminate the Credit Facility on January 28, 2026
• Net cash provided by financing activities was $59,505 for the three months ended March 31, 2026
• Remaining funds from the Offering are available for working capital, capital expenditures, and other general corporate purposes
• Net cash provided by financing activities was $2,382 for the three months ended March 31, 2025
• Proceeds from the exercise of stock options contributed to financing activities in the three months ended March 31, 2026
• Payments of employee tax withholding on vested stock awards in exchange for shares withheld reduced financing cash flows in the three months ended March 31, 2026

Impact estimates